During the past decade, Arizona Research Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Research Associates" #1 sponsor was "Mannkind Corporation" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Mylan Pharmaceuticals Inc" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Research Associates" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Research Associates" are "Diabetes Mellitus" (2 trials), "Arthritis" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Atrophic Vaginitis" (1 trials) and "Chronic Obstructive Pulmonary Disease (COPD)" (1 trials). Many other conditions were trialed in "Arizona Research Associates" in a lesser frequency.

Most popular intervention types in "Arizona Research Associates" are "Drug" (9 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bococizumab (PF-04950615;RN316)" (1 trials), "CTX-100 (formerly ETX-100) (hyaluronic acid)" (1 trials), "Comparator" (1 trials), "Estrace® 0.01% cream" (1 trials) and "Estradiol Vaginal Cream, 0.01%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Research Associates" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Arizona Research Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Arizona Research Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Research Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".